Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

vaccine-covid-inequality

Demonstrators call for the United States to share its Covid-19 vaccine supply during a rally in Los Angeles on June 10, 2021. (Photo by Frederic J. Brown/AFP via Getty Images)

Omicron: Vaccine Nationalism Is Prolonging the Pandemic

As wealthy nations continue hoarding vaccines, new dangerous COVID-19 variants will continue emerging.

Fatima Hassan

 by Al-Jazeera English

The United Kingdom and wealthy European nations are in a panic. Unsurprisingly, hoarding huge swaths of the global vaccine supply has enabled the emergence of dangerous new variants of COVID-19. And once again, rich countries are punishing the victims of global vaccine inequality by slamming shut the borders to anyone from southern African nations.

Of course, the Omicron variant, as the World Health Organization has named it, has not exclusively been found in Southern Africa. Cases have been discovered in Asia and Europe, including in the UK, but the Global South is being blamed for it, while the means to deal with COVID-19 have been kept from it. This is perfectly fitting with how rich countries have dealt with the pandemic.

If we do not want COVID-19 to continue exacerbating the racist and colonial world order, we need change.

At each stage of their response, hopes for collaboration have been junked. Western nations have hoarded—and even binned—vaccines rather than donate them on scale, or on time. For more than a year, the UK and European Union have blocked a proposal from South Africa and India to suspend intellectual property on COVID -19 technologies including vaccines. Most countries in the world recognise this is crucial for scaling up vaccine production to levels needed to end this pandemic. But to leaders like British Prime Minister Boris Johnson, propping up pharmaceutical monopolies is more important.

Just seven percent of people in Africa are fully vaccinated and recent data shows only one in four health workers in Africa are fully protected. This is not just morally grotesque, but also dangerous: it creates a breeding ground for new variants.

As in all parts of the world, African governments have made mistakes in this pandemic. Indeed, my organisation in South Africa, the Health Justice Initiative, has been vocal about our government's errors, including on vaccine contract transparency.

South Africa also had to contend with serious political violence in mid-2021 and the government has changed health ministers twice in 12 months. This has been compounded by devastating job losses and a hunger crisis, worsened by often irrational travel bans.

But South Africa's lingering apartheid-era health system, enduring levels of poverty, and year-long inability to obtain decent amounts of vaccines on time meant the government faced an impossible task. For the better part of 2021, with limited global supplies siphoned by the Global North, South Africa was drip-fed vaccine supplies.

AstraZeneca was at first one of the few vaccines trickling into Africa. But disinformation from Pfizer board member Scott Gottlieb questioning the jab's efficacy and safety, exacerbated by EU leaders, also led to mistrust in the vaccine. Its use was then paused in many African countries, and halted in South Africa, with the emerging Beta variant and Indian export restrictions also factors.

The African Union negotiated a new deal with Johnson & Johnson, via Aspen Pharmacare, a company in South Africa. But most of the 220 to 400 million vaccines promised have still not been delivered. Worse, when it mattered most, during our devastating third wave in South Africa, Johnson & Johnson actually exported millions of vaccines that were filled and finished in South Africa, to highly vaccinated nations in Europe and North America.

In August, working with the South African government and Cape Town-based biotech company Afrigen, the WHO started building the first global manufacturing hub to produce mRNA vaccines and share them with the world, dispelling the racist notion that Africa is unable to safely manufacture vaccines. Shamefully, Moderna and Pfizer have refused to share any knowledge with the hub.

So African scientists are having to reverse-engineer the process themselves, which could take some time. Sensing a PR crisis, these companies are trying to bypass the hub with parallel partial licensing deals. Far from benevolence, these deals seem designed to undermine the WHO's efforts.

Along the way, the litany of delays, misinformation, and the secrecy of corporate vaccine contracts with broad indemnification against liability clauses, have fuelled mistrust of vaccine companies—aided by an increasingly well-oiled anti-vaccine movement and politicians seeking to score points.

We need a different way of doing things. More than 100 states have been pressing for at least a year for an emergency suspension of intellectual property rights on technologies crucial to end the pandemic. The waiver would make it easier for South Africa and other countries to produce vaccines, especially to scale up supplies for everyone and save lives. But it has been blocked repeatedly by the UK and EU countries, for no good reason.

In contrast, South Africa has consistently been a constructive global partner in the pandemic—with hundreds volunteering for vaccine trials and its advanced scientific surveillance systems helping to discover new COVID-19 variants quickly.

If we do not want COVID-19 to continue exacerbating the racist and colonial world order, we need change. And believe it or not, it would benefit the UK and Europe, too. Because you cannot impose rigid policies or build high enough walls to keep the consequences of vaccine inequality out. We need to pull out all of the stops and remove every barrier to vaccine production—and intellectual property is first among them. We need solidarity and cooperation, not knee-jerk travel bans.


© 2021 Al-Jazeera English

Fatima Hassan

Fatima Hassan is a human rights lawyer and social justice activist and the founder of the Health Justice Initiative.

We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.

One Year In, Biden Fails to Boost C- Grade on Environment

The Center for Biological Diversity Action Fund assessment indicates the administration's action to deliver on environmental promises "desperately needs improvement."

Jessica Corbett ·


'A No-Brainer': Lawmakers Urge Pelosi to Hold Vote on Stock Trading Ban

"Perhaps this means some of our colleagues will miss out on lucrative investment opportunities," said House members in a bipartisan letter. "We don't care."

Jessica Corbett ·


Virginia Schools Sue Youngkin Mandate Making Masks Optional

The Republican governor wants to allow parents to decide whether their children should wear masks to school to mitigate Covid-19 transmission—guidance at least 58 school districts have no plans to follow.

Julia Conley ·


US Puts Troops on Standby as War Tensions Over Ukraine Mount

The U.K. threatens "lightning war" as military forces mobilize in eastern Europe.

Andrea Germanos ·


Advocacy Group Urges Pfizer to Combat Paxlovid Inequality

"Help end the pandemic this year around the world," one advocate told Pfizer. "Not just in a handful of rich countries."

Kenny Stancil ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo